Market Cap | 236.75M | P/E | - | EPS this Y | 27.30% | Ern Qtrly Grth | - |
Income | -21.1M | Forward P/E | -11.74 | EPS next Y | - | 50D Avg Chg | -9.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 27.00% |
Dividend | N/A | Price/Book | 19.13 | EPS next 5Y | - | 52W High Chg | -21.00% |
Recommedations | 1.70 | Quick Ratio | 3.14 | Shares Outstanding | 18.65M | 52W Low Chg | 138.00% |
Insider Own | 53.26% | ROA | -60.89% | Shares Float | 6.64M | Beta | 0.46 |
Inst Own | 11.42% | ROE | -128.44% | Shares Shorted/Prior | 0.98M/0.90M | Price | 14.79 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 67,432 | Target Price | 22.00 |
Oper. Margin | - | Earnings Date | Aug 6 | Volume | 44,798 | Change | 7.41% |
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company's lead product candidate is NXP800, a novel small molecule that is in Phase 1b clinical trials for the treatment of patients with platinum-resistant, ARID1a-mutated ovarian carcinoma. It is also developing NXP900, a small molecule drug candidate, which is in Phase 1a clinical trails that inhibits the Proto-oncogene c-Src and YES1 kinases. It has license agreement with the CRT Pioneer Fund for the NXP800 and any of related derivatives; and the University of Edinburgh for the NXP900 and any of associated derivatives. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
HC Wainwright & Co. | Buy | Aug 6, 24 |
HC Wainwright & Co. | Buy | May 8, 24 |
HC Wainwright & Co. | Buy | Sep 15, 23 |
HC Wainwright & Co. | Buy | Mar 7, 23 |
HC Wainwright & Co. | Buy | Feb 10, 23 |
Ladenburg Thalmann | Buy | Jul 13, 22 |
HC Wainwright & Co. | Buy | May 10, 22 |
HC Wainwright & Co. | Buy | Mar 2, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
BENTSUR RON | Chairman & CEO Chairman & CEO | Oct 06 | Buy | 11.23 | 1,080 | 12,128 | 3,236,844 | 10/10/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Oct 04 | Buy | 11.02 | 3,220 | 35,484 | 3,235,764 | 10/06/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Aug 15 | Buy | 14.75 | 350 | 5,162 | 3,232,544 | 08/16/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Aug 08 | Buy | 14.75 | 300 | 4,425 | 3,232,194 | 08/11/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 31 | Buy | 13.88 | 860 | 11,937 | 2,595,000 | 08/01/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 28 | Buy | 13.91 | 2,584 | 35,943 | 2,594,140 | 07/31/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 27 | Buy | 13.98 | 1,556 | 21,753 | 2,591,556 | 07/28/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 26 | Buy | 13.97 | 10,000 | 139,700 | 2,590,000 | 07/27/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 19 | Buy | 14.84 | 8,000 | 118,720 | 2,571,762 | 07/20/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Jul 19 | Buy | 14.33 | 200 | 2,866 | 3,231,559 | 07/20/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 18 | Buy | 14.84 | 9,149 | 135,771 | 2,563,762 | 07/19/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Jul 07 | Buy | 15.61 | 260 | 4,059 | 3,231,359 | 07/18/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 12 | Buy | 15.09 | 3,285 | 49,571 | 2,554,613 | 07/13/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 11 | Buy | 15.36 | 10,000 | 153,600 | 2,551,328 | 07/12/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 07 | Buy | 15.19 | 8,948 | 135,920 | 2,541,328 | 07/10/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 06 | Buy | 15.01 | 3,179 | 47,717 | 2,532,380 | 07/07/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Jul 06 | Buy | 14.88 | 320 | 4,762 | 3,231,099 | 07/07/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jul 05 | Buy | 15.52 | 1,176 | 18,252 | 2,529,201 | 07/06/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jun 26 | Buy | 16.46 | 16,760 | 275,870 | 2,528,025 | 06/27/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Jun 26 | Buy | 16.50 | 750 | 12,375 | 3,230,779 | 06/27/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jun 23 | Buy | 17.43 | 73,175 | 1,275,440 | 2,511,265 | 06/26/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jun 21 | Buy | 17.72 | 13,090 | 231,955 | 2,438,090 | 06/23/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jun 16 | Buy | 17.75 | 12,700 | 225,425 | 2,425,000 | 06/20/23 |
Mosseri Marlio Charles | 10% Owner 10% Owner | Jun 15 | Buy | 17.63 | 32,124 | 566,346 | 2,412,300 | 06/16/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Jun 07 | Buy | 17.47 | 350 | 6,114 | 3,229,529 | 06/08/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | May 31 | Buy | 17.28 | 330 | 5,702 | 3,229,179 | 06/01/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | May 16 | Buy | 17.025 | 320 | 5,448 | 3,228,649 | 05/18/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Mar 23 | Buy | 12.13 | 230 | 2,790 | 3,228,329 | 03/27/23 |
Shemesh Shay | Chief Dev. & Ops. Of.. Chief Dev. & Ops. Officer | Mar 21 | Buy | 11.99 | 420 | 5,036 | 1,361,955 | 03/22/23 |
Shemesh Shay | Chief Dev. & Ops. Of.. Chief Dev. & Ops. Officer | Mar 15 | Buy | 10.71 | 670 | 7,176 | 1,361,535 | 03/17/23 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Nov 30 | Buy | 7.45 | 150 | 1,118 | 3,015,459 | 11/30/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Nov 25 | Buy | 7.41 | 450 | 3,334 | 3,015,309 | 11/29/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Nov 17 | Buy | 7.24 | 750 | 5,430 | 3,014,859 | 11/21/22 |
Shemesh Shay | Chief Dev. & Ops. Of.. Chief Dev. & Ops. Officer | Nov 16 | Buy | 7.15 | 300 | 2,145 | 1,245,365 | 11/18/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Sep 28 | Buy | 7.35 | 1,000 | 7,350 | 3,013,109 | 10/03/22 |
Shemesh Shay | Chief Dev. & Ops. Of.. Chief Dev. & Ops. Officer | Sep 23 | Buy | 7.87 | 220 | 1,731 | 1,245,065 | 09/27/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Sep 23 | Buy | 7.81 | 1,500 | 11,715 | 3,012,109 | 09/27/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Sep 01 | Buy | 8.24 | 1,700 | 14,008 | 3,010,609 | 09/06/22 |
Shemesh Shay | Chief Dev. & Ops. Of.. Chief Dev. & Ops. Officer | Sep 02 | Buy | 8.31 | 404 | 3,357 | 1,244,845 | 09/06/22 |
Shemesh Shay | Chief Dev. & Ops. Of.. Chief Dev. & Ops. Officer | Aug 31 | Buy | 8.07 | 3,006 | 24,258 | 1,244,441 | 09/02/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Aug 23 | Buy | 9.04 | 1,500 | 13,560 | 3,008,909 | 08/30/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Aug 18 | Buy | 8.79 | 19,426 | 170,755 | 3,007,409 | 08/22/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Jun 28 | Buy | 11.72 | 4,000 | 46,880 | 2,968,314 | 06/30/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | Jun 22 | Buy | 12.23 | 700 | 8,561 | 2,964,314 | 06/27/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | May 26 | Buy | 15.82 | 1,000 | 15,820 | 2,963,614 | 05/31/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | May 19 | Buy | 17.62 | 1,200 | 21,144 | 2,962,614 | 05/23/22 |
Shemesh Shay | Chief Dev. & Ops. Of.. Chief Dev. & Ops. Officer | May 20 | Buy | 16.54 | 300 | 4,962 | 1,241,435 | 05/23/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | May 17 | Buy | 19.92 | 2,010 | 40,039 | 2,961,414 | 05/19/22 |
Shemesh Shay | Chief Dev. & Ops. Of.. Chief Dev. & Ops. Officer | May 16 | Buy | 19.42 | 242 | 4,700 | 1,241,135 | 05/18/22 |
BENTSUR RON | Chairman & CEO Chairman & CEO | May 13 | Buy | 18.71 | 1,700 | 31,807 | 2,959,404 | 05/17/22 |